February 9, 2023 Allergy/Immunology First step studying the outcomes of a one-and-done therapy using pegylated interferon lambda demonstrated that it helped curb severe COVID-19 infection-related hospitalizations.
January 19, 2023 Allergy/Immunology Quebec man with debilitating skin condition needs some compassion from the Quebec Government to cover the cost of the medication (that is working) whether or not it was vaccine-related to help him resume a normal life. But they do not seem to care.
January 13, 2023 Allergy/Immunology Headline: “Scientists find potential cure for COVID-related loss of smell.” Not so fast. It concludes that greater improvement with treatment was noted compared to placebo but “there was no subjective olfactory improvement over placebo.”
January 3, 2023 Allergy/Immunology Scientists discover T-cell overactivation as a key reason why long-COVID patients experience long-term smell loss
November 9, 2022 Allergy/Immunology Researchers seek to understand why vaccine responses vary from person to person
October 20, 2022 Allergy/Immunology Amazing study shows how natural selection due to Black Plague in the 14th Century altered subsequent population immune function
September 12, 2022 Allergy/Immunology Tweaking CAR-T activity with on/off switches may reduce cytokine release syndrome.
August 19, 2022 Allergy/Immunology Discovery of largely unchanged ‘weak spot’ in COVID-19 variants could lead to better treatment options
August 10, 2022 Allergy/Immunology A vaccine for Lyme disease is in its Phase 3 trial. Results to date show efficacy and safety. If trial is successful, official authorization expected in 2025.
August 9, 2022 Allergy/Immunology Scientists from Johns Hopkins University have genetically engineered an experimental nanobody that targets alpha-synuclein protein clumps thought to be involved in the pathophysiology of Parkinson’s disease